Cayuga Biotech

Coagulant Therapeutics

This company develops medicines to treat acute bleeding conditions, such as postpartum haemorrhage and traumatic brain injury, for patients with urgent medical needs.

ClotProtect

This therapeutics company develops a small molecule drug to treat acute bleeding and improve survival for patients suffering from trauma or undergoing surgery.

Clotprotect Therapeutics

This company develops small molecule anti-fibrinolytic drugs for patients suffering from acute haemorrhage and severe bleeding.

VarmX

This biotech company develops recombinant blood clotting factors to treat patients with severe bleeding or requiring urgent surgery while taking oral anticoagulants.

Alveron Pharma

Alveron Pharma develops a cyclodextrin-based injectable drug that reverses anticoagulant and antiplatelet effects for patients experiencing life-threatening bleeding emergencies and haemorrhagic strokes.

Sealonix

This company develops bioabsorbable hemostatic sealant patches to control surgical bleeding for healthcare providers performing abdominopelvic and orthopaedic procedures.

Haermonics

This company develops automated pericardial flushing systems to prevent blood clots and drainage complications for patients recovering from open-heart surgery.

410 Medical

This company develops handheld rapid infusion devices to deliver fluids and blood to critically ill patients for hospitals and emergency medical services.